Evaluation of the efficacy and the safety of soy protein on human muscle metabolism 3.On the healthy subject

Evaluation of the efficacy and the safety of soy protein on human muscle metabolism 3.On the healthy subject - Clinical trial of intake of soybean protein ingredients 3.On the healthy subject

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007444

Enrollment

Registered

2012-03-27

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subject

Interventions

Soybean protein ingredient Powdered cazein(Milk)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Subject must be aged>20 years. 2)Both men and women 3)Subject who consent to participate in this study in person.

Exclusion criteria

Exclusion criteria: 1)Chronic kidney disease 2)Neural and muscle disease 3)History of breast cancer 4)Subject who have soybean allergy and milk allergy. 5)Subject who take the health food supplement including the soybean. 6)Pregnant female, lactating female 7)History of allergy to local anesthetics such as lidocaine. 8)Subject who can't undergo MRI scan. 9)Subject who have been enrolled in this study within the last 2weeks. 10)The case that subject refuse to participate in this study. 11)The case that it is difficult to participate in this study in the opinion of the investigator.

Design outcomes

Primary

Measure	Time frame
1)Volume of large hamstring muscles 2)Marker of muscle athropy(3Met-His, CK) 3)Marker of oxidative stress(8-OHdG) 4)Muscle strength 5)Ubiquitination of muscle protein 6)Expression of genes involved in muscle atrophy	—

Countries

Japan

Contacts

Public ContactTakeshi Nikawa

The University of Tokushima Graduate School of Nutrition and Bioscience -Nutritional Physiology

nikawa@nutr.med.tokushima-u.ac.jp088-633-9247

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026